|
|
Article: Ranbaxy gets final USFDA approval for anti-depressant.
- Article from:
- PTI - The Press Trust of India Ltd.
- Article date:
- February 8, 2007
CopyrightCOPYRIGHT 2007 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ranbaxy gets final USFDA approval for anti-depressant
Mumbai, Feb 8 (PTI) Pharma major Ranbaxy Laboratories Ltd today said it has received US Food and Drug Administration (USFDA) approval for its anti-depressant Sertraline Hydrochloride tablets in various dosages.
In a filing to the Bombay Stock Exchange, the pharma giant said, "the office of generic drugs, USFDA, has determined the company's formulation to be bioequivalent and to have the same therapeutic effect as that of the reference listed drug Zoloft Tablets of Pfizer Pharmaceuticals, Inc." The approval from the U S Food and Drug Administration (FDA) would allow the company to manufacture and ...